ASPIRE Gene Therapy for Hemophilia 2017 | Apply

Applicant Eligibility

To be eligible for an award, applicants must have an advanced professional degree (MD, PhD, PharmD, DNP, DPT, etc. or equivalent).

Timeline for Application

  • Applications must be received by 31 May 2018, 11:59pm New York Eastern Daylight Time in the United States
  • Addenda, supplemental materials, changes, or updates will not be accepted after the deadline
  • Notification of Awards recipients will be in July 2018
  • The final study results or an interim progress report is expected on or before December 31, 2020

How to Apply

Applications are to be submitted to Pfizer through an online submission website. Please click on the link below to be routed to Pfizer’s global investigator-initiated research website. Click on “Submit an IIR Request” and follow the online instructions. If this is your first time visiting the portal you must first “Create an Account”.

Please select 2018 ASPIRE Global Gene and anti-TFPI Therapies for Hemophilia Awardsfrom the competitive program dropdown. The system will automatically populate the study title with correct program ID.

Completed application forms must be accompanied by the following documents:

  • Cover letter on institutional letterhead
  • Relevant articles from the applicant’s scientific publications (if applicable)
  • Description of preliminary work in proposed research topic
  • An abbreviated curriculum vitae (CV) (limited to 3 pages); NIH biosketch format will be accepted
  • Description of available research facilities, and mentorship opportunities (if a young investigator)
  • Listing of other research support with a description of overlap with ASPIRE application, if any, and, if applicable, a listing of proposed collaborators (including CVs)
  • Bibliography of relevant references
  • Itemized budget for proposed research

Application Process

For ONLINE SUBMISSION INSTRUCTIONS click here 

To Apply for a 2018 ASPIRE Global Gene and anti-TFPI therapies in Hemophilia Award Click Here

Questions

Please see the Frequently Asked Questions (FAQ) page for help.

You may also e-mail questions to  Questions.Aspireresearch-Hemophilia_Gene_aTFPI_therapies@pfizer.com